| |
 |
|
|
|
|
|
Poster: 135
Visits: 42
Title: Survival And Morbidity Following Stereotactic Radiotherapy Of Hepatocellular Carcinoma: A 10 Year Single Institution Experience.
Authors: Hanna Mortensen , Villadsen GE, Department of Hepatology and Gastroenterology, Aarhus University HospitalWorm E, Department of Medical Physics, Aarhus University Hospital Weber B, Department of Oncology, Aarhus University Hospital and Danish Center of ParticleTherapy, Aarhus University Hospital
Centre:
|
|
You must be registered to reply or comment.
|
|
SURVIVAL AND MORBIDITY FOLLOWING STEREOTACTIC RADIOTHERAPY OF HEPATOCELLULAR CARCINOMA: A 10 YEAR SINGLE INSTITUTION EXPERIENCE.
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre:
|
|
|
|
